Concurrent Ocular and Cerebral Toxoplasmosis in a Liver Transplant Patient Treated with Anti-CD40 Monoclonal Antibody

<div>MRI imaging (T2 images, sagittal view) at presentation (a) and during follow-up (b) 5 weeks of TMP-SFX twice daily; (c) 20 weeks follow-up, of which 6 weeks of TMP-SFX 4 times a day and 14 weeks twice daily. Gradual improvement of the lesion was seen during treatment (highlighted by arrow).</div>

Case Reports in Infectious Diseases

fig1

Figure 1

Figure 1: Concurrent Ocular and Cerebral Toxoplasmosis in a Liver Transplant Patient Treated with Anti-CD40 Monoclonal Antibody 